GSK relates its experience of adopting a digital twin technology initiative for its vaccine business on the latest episode of the BioProcess Insider Expression Platform podcast.

A digital twin is a virtual representation that serves as the real-time digital counterpart of a physical object or process. Biopharma giant GlaxoSmithKline (GSK) has adopted this technology to advance its vaccine development and manufacturing division.

Matt Harrison, head of Sciences, Digital Innovation and Business Strategy at GSK

A year after partnering with Siemens and Atos to pilot a digital twin in order to create a real-time simulation of the entire vaccine manufacturing process, we sat down (virtually, sadly) with Matt Harrison, head of Sciences, Digital Innovation and Business Strategy at GSK to discuss the current status of this project.

As well as describing the benefits of a digital twin, Harrison spoke about how the COVID-19 pandemic helped drive this approach and how GSK plans to expand and replicate this model for the production of all future vaccines.

Listen to it below, or on iTunes, Google Podcasts, Spotify, or wherever you get your podcasts.